Robyn Hamel

Robyn Hamel is an experienced administrative professional with a strong background supporting executives in the biotechnology and healthcare sectors. Currently serving as a Senior Executive Assistant at Dyno Therapeutics since July 2025, Robyn previously held roles as an Executive Assistant at Abata Therapeutics and Ipsen, as well as supporting the CEO at Sigilon Therapeutics, Inc. Robyn's extensive experience includes positions at Bioverativ, Bain Capital, and Beth Israel Deaconess Medical Center, where administrative contributions were made to various research programs. Additionally, Robyn has operational experience from roles at Consumer Marketing Solutions and Hachette Book Group USA. Robyn Hamel holds a degree from the University of Massachusetts Amherst.